TELL
PrivateLast Round
Grant
May 1, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
TELL operates in Healthcare & Life Sciences and is based in Montevideo. Its latest recorded funding round was a Grant round in May 2025.
TELL is a health technology company that provides a web-based platform for automated speech and language analysis to assess and monitor neurocognitive health.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TELL Comparables
Compare TELL with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LangAware | 89% | |
| Novoic | 83% | |
| neurodAIgnostics AG | 82% |
For institutional investors. Book with your work email.
TELL Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2025 | ||||
| Accelerator | Oct 24, 2024 | ||||
| Accelerator | Jul 26, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TELL Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartUp Health | Accelerator |
| Agencia Nacional de Investigación e Innovación | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 148% MoM.
- Jun 20, 2026
Monthly visitors increased 442% from 92 to 499.
For institutional investors. Book with your work email.
TELL Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TELL's valuation, stock price, and market status.
Is TELL a public or private company?
TELL is a private company.
What is the current stock price of TELL?
TELL is a private company, so its shares have no public market price. Caplight tracks TELL's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TELL worth (valuation)?
Valuation information for TELL is not publicly available.
Can I buy TELL stock?
TELL shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TELL's last funding round?
TELL's most recent funding round was Grant on May 1, 2025.
Who are the main investors in TELL?
Key investors in TELL include StartUp Health, Agencia Nacional de Investigación e Innovación.
Will TELL IPO soon?
No public IPO plans have been announced for TELL.
How can I track TELL secondary market activity?
Caplight tracks bids, offers, and trades in TELL's shares on secondary markets.